38632611|t|Choroid plexus enlargement in amyotrophic lateral sclerosis patients and its correlation with clinical disability and blood-CSF barrier permeability.
38632611|a|BACKGROUND: Using in vivo neuroimaging techniques, growing evidence has demonstrated that the choroid plexus (CP) volume is enlarged in patients with several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. However, although animal and postmortem findings suggest that CP abnormalities are likely important pathological mechanisms underlying amyotrophic lateral sclerosis (ALS), the third most common neurodegenerative disease, no available study has been conducted to thoroughly assess CP abnormalities and their clinical relevance in vivo in ALS patients to date. Thus, we aimed to determine whether in vivo CP enlargement may occur in ALS patients. We also aimed to identify the relationships of CP volume with clinical disabilities and blood-CSF barrier (BCSFB) permeability in ALS patients. METHODS: In this retrospective study, based on structural MRI data, CP volume was assessed using a Gaussian mixture model and underwent further manual correction in 155 ALS patients and 105 age- and sex-matched HCs from October 2021 to April 2023. The ALS Functional Rating Scale-Revised (ALSFRS-R) was used to assess clinical disability. The CSF/serum albumin quotient (Qalb) was used to assess BCSFB permeability. Moreover, all the ALS patients completed genetic testing, and according to genetic testing, the ALS patients were further divided into genetic ALS subgroup and sporadic ALS subgroup. RESULTS: We found that compared with HCs, ALS patients had a significantly higher CP volume (p < 0.001). Moreover, compared with HCs, CP volume was significantly increased in both ALS patients with and without known genetic mutations after family-wise error correction (p = 0.006 and p < 0.001, respectively), while there were no significant differences between the two ALS groups. Furthermore, the CP volume was significantly correlated with the ALSFRS-r score (r = -0.226; p = 0.005) and the Qalb (r = 0.479; p < 0.001) in ALS patients. CONCLUSION: Our study first demonstrates CP enlargement in vivo in ALS patients, and continues to suggest an important pathogenetic role for CP abnormalities in ALS. Moreover, assessing CP volume is likely a noninvasive and easy-to-implement approach for screening BCSFB dysfunction in ALS patients.
38632611	0	26	Choroid plexus enlargement	Disease	MESH:D020288
38632611	30	59	amyotrophic lateral sclerosis	Disease	MESH:D000690
38632611	60	68	patients	Species	9606
38632611	94	102	clinical	Disease	MESH:D000075902
38632611	286	294	patients	Species	9606
38632611	308	334	neurodegenerative diseases	Disease	MESH:D019636
38632611	346	365	Alzheimer's disease	Disease	MESH:D000544
38632611	370	389	Parkinson's disease	Disease	MESH:D010300
38632611	453	469	CP abnormalities	Disease	MESH:D020288
38632611	526	555	amyotrophic lateral sclerosis	Disease	MESH:D000690
38632611	557	560	ALS	Disease	MESH:D000690
38632611	585	610	neurodegenerative disease	Disease	MESH:D019636
38632611	671	687	CP abnormalities	Disease	MESH:D020288
38632611	698	706	clinical	Disease	MESH:D000075902
38632611	728	731	ALS	Disease	MESH:D000690
38632611	732	740	patients	Species	9606
38632611	822	825	ALS	Disease	MESH:D000690
38632611	826	834	patients	Species	9606
38632611	898	919	clinical disabilities	Disease	MESH:D009069
38632611	966	969	ALS	Disease	MESH:D000690
38632611	970	978	patients	Species	9606
38632611	1149	1152	ALS	Disease	MESH:D000690
38632611	1153	1161	patients	Species	9606
38632611	1232	1235	ALS	Disease	MESH:D000690
38632611	1298	1306	clinical	Disease	MESH:D000075902
38632611	1414	1417	ALS	Disease	MESH:D000690
38632611	1418	1426	patients	Species	9606
38632611	1492	1495	ALS	Disease	MESH:D000690
38632611	1496	1504	patients	Species	9606
38632611	1539	1542	ALS	Disease	MESH:D000690
38632611	1565	1568	ALS	Disease	MESH:D000690
38632611	1621	1624	ALS	Disease	MESH:D000690
38632611	1625	1633	patients	Species	9606
38632611	1759	1762	ALS	Disease	MESH:D000690
38632611	1763	1771	patients	Species	9606
38632611	1949	1952	ALS	Disease	MESH:D000690
38632611	2104	2107	ALS	Disease	MESH:D000690
38632611	2108	2116	patients	Species	9606
38632611	2185	2188	ALS	Disease	MESH:D000690
38632611	2189	2197	patients	Species	9606
38632611	2259	2275	CP abnormalities	Disease	MESH:D020288
38632611	2279	2282	ALS	Disease	MESH:D000690
38632611	2383	2400	BCSFB dysfunction	Disease	MESH:C536830
38632611	2404	2407	ALS	Disease	MESH:D000690
38632611	2408	2416	patients	Species	9606

